Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT

Jacopo Romagnoli, Franco Citterio, Gionata Spagnoletti, Maria Paola Salerno, Flavia De Gennaro

Research output: Contribution to journalConference article

Abstract

Introduction. Combination of Everolimus (EVR) with Tacrolimus (Tac) permits reduced calcineurin inhibitors exposure and, recently, has been demonstrated safe and effective. Two different once-daily Tacrolimus formulations, with different pharmacokinetic profiles are now available: ER-Tac and LCPT. Aim of this study was to compare in kidney transplant recipients (KTx), the short-term efficacy and safety of ER-Tac versus LCPT, both in combination with EVR, administered concomitantly once a day. Methods. Fifty-seven KTx were open randomized to once-daily maintenance immunosuppressive regimen based on ER-Tac + EVR + Steroids (ER-Tac+EVR, n=30) or LCPT + EVR + Steroids (LCPT+EVR, n=27). All patients received induction therapy with Thymoglobuline (total dose 200 mg). Results vMedian follow-up was 10 months (range 3-18). Here we present the intention-to-treat analysis at 6 months. There were no differences in patients as well as in graft survival. Moreover, we found no differences in renal function, acute rejection rate, CMV infection. According to the Concentration/Dose ratio of Tacrolimus, there was a significantly higher number of slow metabolizers 1-month after transplant in the LCPT+EVR group. Our data show that the two extended release Tac formulations, when administered with EVR once-daily, have comparable 6-month safety and efficacy. We can speculate that the higher number of slow metabolizers in the LCPT group may be an advantage to reach target exposure early after transplantation.
Original languageEnglish
Pages (from-to)690-691
Number of pages2
JournalAmerican Journal of Transplantation
Volume19
Publication statusPublished - 2019
EventAmerican Transplant Congress - ATC - Boston, Massachussetts, USA
Duration: 1 Jan 2019 → …

Keywords

  • kidney transplant

Fingerprint

Dive into the research topics of 'Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT'. Together they form a unique fingerprint.

Cite this